114 results
Page 2 of 6
SC14D9C
EX-99.5
xoika96e0o915kjac29a
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-99.1
idmdz gge
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC TO-C
EX-99.1
yk1zmvs8qx4sqgh8qk
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
s4vfjts8x7
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
txzujb
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
bdxnnxs0kq
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
bggyck6t 63i
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
rpis27j
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
akw7z8ltgn sx
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
p9ml2fhgwelt 36rj
3 Oct 23
Tender and Support Agreement
7:35am
ARS
e29fu1v
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
6nqlsiv7w m3zuz44
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm